How Does Sustained Virologic Response of Hepatitis C Affect Long-Term Health?March 28th 2019
An increasing number of patients with decompensated cirrhosis are receiving direct-acting antiviral treatment and attaining sustained virologic response of hepatitis C, however, their long-term outcomes are unclear.
Hepatitis C Antivirals Reduce All-Cause Mortality, Liver CancerFebruary 21st 2019
Longitudinal study of direct-acting antivirals for hepatitis C virus infection finds that treatment provides clinical benefit beyond virologic response, reducing risk for both all-cause mortality and for liver cancer.
Researchers Link Oxycodone Abuse Deterrent Formulation to HCV SurgeFebruary 6th 2019
The 2010 remanufacturing of Purdue Pharma's OxyContin (oxycodone) into an "abuse-deterrent formulation" has been identified as a key contributing factor in opioid abusers switching to heroin injections and the corresponding surge in hepatitis C virus (HCV) infections, according to a new Rand Corporation study.